Vinblastine and Interferon-Gamma Combination with and without 13-Cis Retinoic Acid for Patients with Advanced Renal Cell Carcinoma — C. Bacoyiannis (2002) | RDL Network
The use of IFN-gamma does not enhance the low response of VBL-based chemotherapy. The additional administration of 13-CRA with the combination of VBL and IFN-gamma does not add to the efficacy of this combination in patients with advanced renal cell carcinoma. New active agents are needed to treat patients with this disease.
Zacharias Kyriakakis, Meletios A Dimopoulos, A. Kostakopoulos, Aristidis Karayiannis, F. Sofras, Anastasios Zervas, Aristidis Giannopoulos, C Dimopoulos
Aristotle Bamias, Lia A. Moulopoulos, Aggelos Koutras, Gerasimos Aravantinos, George Fountzilas, D. Pectasides, Efstathios Kastritis, D. Gika, Dimosthenis Skarlos, Helena Linardou, Haralabos P. Kalofonos, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.